Fig. 3 (Abstract A9).From: Abstracts of the 35th Meeting of the German Society for Pediatric and Adolescents Rheumatology (Gesellschaft für Kinder- und Jugendrheumatology (GKJR)Initiations of Biologic DMARDs in sJIA: IL-1 Inhibitors, IL-6 Inhibitors, TNFα Inhibitors and other Biologics (%)Back to article page